tm
Seeing Is Believing
tm
Seeing Is Believing
Eidos Therapeutics's activity chart (see below) currently has 25 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 86.11% with an average time for these price targets to be met of 92.33 days.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 29-Dec-2020. First documented stock forecast 16-Jul-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Dec-2020
$129
$6.79 (5.56%)
$73.26
5 years 9 months 3 days ago
(29-Dec-2020)
3/3 (100%)
$4.39 (3.52%)
24
Buy Since 17-Apr-2019
$56
5 years 10 months 14 days ago
(18-Nov-2020)
2/2 (100%)
$19.77 (54.57%)
59
Buy Since 22-Jul-2019
$73.26
$-48.95 (-40.05%)
$80
5 years 11 months 27 days ago
(05-Oct-2020)
3/3 (100%)
$-0.25 (-0.34%)
128
Buy Since 30-Oct-2019
$59
$-63.21 (-51.72%)
$59
5 years 11 months 27 days ago
(05-Oct-2020)
2/3 (66.67%)
$-14.51 (-19.74%)
84
Buy Since 16-Jul-2018
6 years 4 months 18 days ago
(14-May-2020)
2/2 (100%)
$16.9 (139.67%)
237
What is EIDX (Eidos Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on EIDX (Eidos Therapeutics)?
Which analyst has the most public recommendations on EIDX (Eidos Therapeutics)?
Which analyst is the currently most bullish on EIDX (Eidos Therapeutics)?
Which analyst is the currently most reserved on EIDX (Eidos Therapeutics)?
